Evidence map›Paper›PMID 38938224›Full record

ArticleLung Cancer (Auckland, N.Z.)2024

Top 20

Sai-Hong Ignatius Ou, Xiuning Le, Misako Nagasaka, Thanyanan Reungwetwattana, Myung-Ju Ahn, Darren W T Lim, Edgardo S Santos, Elaine Shum, Sally C M Lau, Jii Bum Lee and 11 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Lung Cancer (Auckland, N.Z.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Sai-Hong Ignatius OuUniversity of California Irvine School of Medicine, Chao Family Comprehensive Cancer Center, Orange, CA, USA.ORCID 0000-0002-1764-4975
Xiuning LeUniversity of Texas MD Anderson Cancer Center, Houston, TX, USA.
Misako NagasakaUniversity of California Irvine School of Medicine, Chao Family Comprehensive Cancer Center, Orange, CA, USA.ORCID 0000-0001-5308-615X
Thanyanan ReungwetwattanaDivision of Medical Oncology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.ORCID 0000-0002-3147-7640
Myung-Ju AhnDepartment of Hematology and Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Darren W T LimDuke-NUS School of medicine, National Cancer Center Singapore, Republic of Singapore.
Edgardo S SantosCharles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, 33431, USA.ORCID 0000-0003-0776-4903
Elaine ShumNYU Langone Perlmutter Cancer Center, NY, NY, USA.
Sally C M LauNYU Langone Perlmutter Cancer Center, NY, NY, USA.
Jii Bum LeeYonsei Cancer Center Yonsei University, Seoul, Republic of Korea.ORCID 0000-0001-5608-3157
Antonio CallesDepartment of Medicine, Division of Medical Oncology, Early Drug Development and Phase I Unit, Hospital General Universitario Gregorio Marañón, Madrid, 28007, Spain.
Fengying WuShanghai Chest hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.
Gilberto LopesDepartment of Medicine, Division of Medical Oncology, Sylvester Comprehensive Cancer Center at the University of Miami and the Miller School of Medicine, Miami, FL, 33136, USA.
Virote SriuranpongChulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.ORCID 0000-0002-7847-894X
Junko TanizakiDepartment of Medicine, Kindai University School of Medicine, Osaka, Japan.
Hidehito HorinouchiDepartment of Thoracic Oncology, National Cancer Center Hospital Tokyo, Tokyo, Japan.
Marina C GarassinoDepartment of Medicine, Division of Medical Oncology-Hematology, University of Chicago Medicine, Chicago, IL, USA.
Sanjay PopatRoyal Marsden Hospital, London, Imperial College, London, UK.
Benjamin BesseGustave Roussy Cancer Campus, Villejuif, France; Paris-Saclay University, Orsay, France.
Rafael RosellDepartment of Hematology-Oncology, National University Cancer Institute, National University Hospital Singapore, Republic of Singapore.ORCID 0000-0003-0817-3400
Ross A SooIOR, Quirón-Dexeus University Institute; ICO, Catalan Institute of Oncology; IGTP, Germans Trias i Pujol Research Institute, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The year 2024 is the 20

Indexed as

20th anniversaryEGFR mutationsexpert panelNSCLCtop 20 papers

Identifiers

PMID38938224
PMCPMC11208875

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.